Onyia Jude
Chief Scientific Officer
Onyia Jude has filed 10 SEC Form 4 filings (22 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Sep 15, 2026.
On the most recent filing, Onyia Jude is listed as Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC. Inside the rolling window, Onyia Jude reported no open-market purchases and 2 open-market sales totaling $3.5M in NBIX. The largest disclosed transaction in the window is a sale of 11,000 NBIX shares on Jun 1, 2026, worth $1.8M.
Companies traded
Other insiders at NBIX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Onyia Jude made?
Onyia Jude has filed 10 SEC Form 4 filings (22 transaction rows) across 1 company since 2025.
Which companies does Onyia Jude trade?
Onyia Jude has filed SEC Form 4 disclosures for 1 company, including NBIX.
When was Onyia Jude's most recent SEC Form 4 filing?
Onyia Jude's most recent SEC Form 4 filing on Tracefour is dated Sep 15, 2026.
What is Onyia Jude's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Onyia Jude is listed as Chief Scientific Officer.
What is Onyia Jude's total buy and sell value in the current window?
Inside the rolling retention window, Onyia Jude bought $0 and sold $3.5M based on SEC Form 4 filings.
What was Onyia Jude's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,000 NBIX shares on 2026-06-01, worth $1.8M, per SEC Form 4 filings.